Molina Healthcare (MOH) Faces Mixed Q4 Results: Is Medicaid Profitability Now the Core Investment Question?

Simply Wall St.16:31

Molina Healthcare recently reported mixed fourth-quarter 2025 results, with higher total revenue but an adjusted loss per share that fell short of analyst expectations due to unfavorable retroactive ...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2614870796?lang=en_US&edition=fundamental","thumbnail":"https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151","is_english":true,"pubTime":"2026-02-25 16:31","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2614870796","market":"sg","top_or_hot":-1,"title":"Molina Healthcare (MOH) Faces Mixed Q4 Results: Is Medicaid Profitability Now the Core Investment Question?","media":"Simply Wall St.","content":"<div>\n<p>Molina Healthcare recently reported mixed fourth-quarter 2025 results, with higher total revenue but an adjusted loss per share that fell short of analyst expectations due to unfavorable retroactive ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-moh/molina-healthcare/news/molina-healthcare-moh-faces-mixed-q4-results-is-medicaid-pro\">Source Link</a>\n\n</div>\n","source":"simplywall_highlight","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Molina Healthcare (MOH) Faces Mixed Q4 Results: Is Medicaid Profitability Now the Core Investment Question?</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMolina Healthcare (MOH) Faces Mixed Q4 Results: Is Medicaid Profitability Now the Core Investment Question?\n</h2>\n\n<h4 class=\"meta\">\n\n\n2026-02-25 16:31 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://simplywall.st/stocks/us/healthcare/nyse-moh/molina-healthcare/news/molina-healthcare-moh-faces-mixed-q4-results-is-medicaid-pro><strong>Simply Wall St.</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>Molina Healthcare recently reported mixed fourth-quarter 2025 results, with higher total revenue but an adjusted loss per share that fell short of analyst expectations due to unfavorable retroactive ...</p>\n\n<a href=\"https://simplywall.st/stocks/us/healthcare/nyse-moh/molina-healthcare/news/molina-healthcare-moh-faces-mixed-q4-results-is-medicaid-pro\">Source Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SG9999014013.SGD","symbol_name":"United Global Durable Equities Fund Dis SGD","start_time":0,"source_url":"https://simplywall.st/stocks/us/healthcare/nyse-moh/molina-healthcare/news/molina-healthcare-moh-faces-mixed-q4-results-is-medicaid-pro","article_id":"2614870796","we_media_id":null,"thumbnails":["https://images.simplywall.st/asset/industry/6034000-choice2-main-header/1585187286151"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nyse-moh/molina-healthcare/news/molina-healthcare-moh-faces-mixed-q4-results-is-medicaid-pro","rn_cache_url":null,"directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2614870796","pubTimestamp":1772008294,"columns":[],"sourceInfo":{"source_id":"simplywall_highlight","name":"Simply Wall St."},"weMediaInfo":null,"summary":"Molina Healthcare recently reported mixed fourth-quarter 2025 results, with higher total revenue but an adjusted loss per share that fell short of analyst expectations due to unfavorable retroactive revenue items and operational pressures in its Medicaid business.\nThese results have prompted several analysts to downgrade their ratings, highlighting concerns about Molina’s ability to sustain Medicaid profitability amid declining premium revenue guidance and volatile revenue and expense...","collect":0,"end_time":0,"defaultTopTitle":"simplywall.st","property":[],"viewcount":null,"language":"en","relate_stocks":{"SG9999014013.SGD":"United Global Durable Equities Fund Dis SGD","BK4588":"碎股","MOH":"Molina Healthcare Inc","SG9999014021.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) ACC","BK4154":"管理型保健护理","BK7104":"黄金","BK4585":"ETF&股票定投概念","XBI":"SPDR S&P Biotech ETF","BK4581":"高盛持仓","SG9999014039.USD":"UNITED GLOBAL DURABLE EQUITIES (USDHDG) INC","MOH.AU":"MOHO RESOURCES LTD","LABU":"三倍做多标普生物-Direxion","BK4532":"文艺复兴科技持仓","XLV":"健康照护类股ETF-SPDR","SG9999014005.SGD":"United Global Durable Equities Fund Acc SGD"},"translate_title":"Molina Healthcare(MOH)第四季度业绩好坏参半：医疗补助盈利能力现在是核心投资问题吗？","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MOH.AU":1.5,"LABU":0.6,"MOH":1.5,"XLV":1.5,"XBI":0.6},"content_text":"Molina Healthcare recently reported mixed fourth-quarter 2025 results, with higher total revenue but an adjusted loss per share that fell short of analyst expectations due to unfavorable retroactive revenue items and operational pressures in its Medicaid business. These results have prompted several analysts to downgrade their ratings, highlighting concerns about Molina’s ability to sustain Medicaid profitability amid declining premium revenue guidance and volatile revenue and expense accruals. Next, we’ll examine how analyst concerns about Medicaid profitability and guidance uncertainty might reshape Molina Healthcare’s existing investment narrative and outlook. Capitalize on the AI infrastructure supercycle with our selection of the 33 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.AdvertisementMolina Healthcare Investment Narrative RecapTo own Molina Healthcare, you need to believe that its Medicaid focused model can remain profitable despite policy and operational headwinds. The latest quarter complicates that belief in the near term, as weaker Medicaid results and lower premium revenue guidance directly pressure the current earnings recovery catalyst while reinforcing the key risk around program funding, rate adequacy, and the reliability of revenue and expense accruals. Among recent announcements, the updated 2026 outlook stands out. Management now guides to lower premium revenue and reduced EPS for 2026, which aligns with analyst concerns about Medicaid profitability and adds near term uncertainty around how quickly earnings can stabilize. This guidance reset may temper earlier expectations that new contracts and rate adjustments would be a clean driver of improvement, at least until there is clearer evidence that medical cost trends and accrual volatility are under control. Yet beneath these concerns, one risk that investors should be aware of is how Molina’s heavy reliance on government sponsored Medicaid plans could... Read the full narrative on Molina Healthcare (it's free!)Molina Healthcare's narrative projects $50.7 billion revenue and $1.3 billion earnings by 2028. This requires 6.8% yearly revenue growth and roughly a $0.2 billion earnings increase from $1.1 billion today.Uncover how Molina Healthcare's forecasts yield a $186.69 fair value, a 26% upside to its current price.Exploring Other PerspectivesMOH 1-Year Stock Price Chart Some of the most optimistic analysts were previously modeling revenue of about US$53.7 billion and earnings near US$1.5 billion, but the latest Medicaid driven setback raises fair questions about whether that faster growth and margin recovery path still holds, or whether the concentrated government program risk they downplayed becomes more central to your own view.Explore 12 other fair value estimates on Molina Healthcare - why the stock might be worth just $176.14!Reach Your Own ConclusionDisagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.A great starting point for your Molina Healthcare research is our analysis highlighting 3 key rewards and 1 important warning sign that could impact your investment decision.Our free Molina Healthcare research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Molina Healthcare's overall financial health at a glance.Curious About Other Options?The market won't wait. These fast-moving stocks are hot now. Grab the list before they run:The latest GPUs need a type of rare earth metal called Terbium and there are only 30 companies in the world exploring or producing it. Find the list for free.This technology could replace computers: discover 22 stocks that are working to make quantum computing a reality.Invest in the nuclear renaissance through our list of 84 elite nuclear energy infrastructure plays powering the global AI revolution.  This article by Simply Wall St is general in nature. We provide commentary based on historical data\n    and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your\n    financial situation. We aim to bring you long-term focused analysis driven by fundamental data.\n    Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.\n    Simply Wall St has no position in any stocks mentioned.New: Manage All Your Stock Portfolios in One PlaceWe've created the ultimate portfolio companion for stock investors, and it's free.• Connect an unlimited number of Portfolios and see your total in one currency• Be alerted to new Warning Signs or Risks via email or mobile• Track the Fair Value of your stocksTry a Demo Portfolio for FreeHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.36.2","shortVersion":"4.36.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2614870796","isCrawlerRequest":true}